EN DE
STOCK COMPARISON

Jia Jie Biomedical Co vs Nestle India: Fair Value & Quality

Both stocks run through our valuation models. Here is how Jia Jie Biomedical Co (4109) and Nestle India (NESTLEIND) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Jia Jie Biomedical Co as the less overvalued of the two: Jia Jie Biomedical Co trades at TWD 11.30 versus a fair value of TWD 6.12 (-46%), while Nestle India trades at ₹1,529 versus ₹362 (-76%).
Jia Jie Biomedical Co
4109.TWO · TWD · Consumer Staples
-46%
upside to fair value
overvalued
PriceTWD 11.30
Fair ValueTWD 6.12
Quality19/100
Nestle India
NESTLEIND.NSE · INR · Consumer Staples
-76%
upside to fair value
overvalued
Price₹1,529
Fair Value₹362
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Jia Jie Biomedical CoNestle India
Valuation
26.7×P/E (TTM)78.9×
2.80×P/S (TTM)11.91×
0.81×P/B
EV/EBITDA53.1×
1.8%Dividend yield0.8%
TWD 0.20Dividend per share₹12.00
Profitability
11%Net margin15%
2%Operating margin23%
3%Return on equity76%
-0%Return on assets23%
Growth
2%Revenue growth (YoY)23%
15.2%Avg. growth/yr (3Y)11.3%
12.4%Avg. growth/yr (5Y)11.7%
Balance & size
Debt / equity0.00×
$42MMarket cap$29B
expensiveGrowth qualityhealthy

Even match: 5 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Jia Jie Biomedical Coof which business quality 24 · market factors 36 Nestle Indiaof which business quality 73 · market factors 78
ProfitabilityMargins and returns on capital today
26
93
Quality GrowthAre margins and returns improving?
15
50
CashflowEarnings quality: real cash, not paper profit
7
75
Fin. StrengthBalance sheet, leverage, solvency risk
73
76
InvestmentDisciplined investing over empire-building
4
42
Low VolatilityCalm price path (market factor)
82
93
MomentumPrice trend over the last 3–12 months (market factor)
21
63
52W MomentumDistance to the 52-week high (market factor)
10
88
Net IssuanceBuybacks instead of dilution
0
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Jia Jie Biomedical Co

Earnings-BasedTWD 3.04
Dividend DiscountTWD 4.41
MultiplesTWD 5.52
Asset-BasedTWD 9.50
Economic ProfitTWD 6.00
Growth EarningsTWD 6.73

14 of 14 models see the stock below the current price.

Nestle India

DCF Models₹451
Earnings-Based₹208
Dividend Discount₹229
Multiples₹278
Asset-Based₹17.92
Growth DCF₹402
Economic Profit₹198
Growth Earnings₹324

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Jia Jie Biomedical Co
Bear TWD 4.59Fair Value TWD 6.12Bull TWD 7.43
TWD 11.30 = current price (white tick)
Nestle India
Bear ₹273Fair Value ₹362Bull ₹452
₹1,529 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Jia Jie Biomedical Co · Consumer Staples

Quality score19 · bottom 25%
Fair value upside-46% · bottom 25%

Nestle India · Consumer Staples

Quality score72 · Top 25%
Fair value upside-76% · bottom 25%

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Jia Jie Biomedical Co as the less overvalued of the two: Jia Jie Biomedical Co trades at TWD 11.30 versus a fair value of TWD 6.12 (-46%), while Nestle India trades at ₹1,529 versus ₹362 (-76%).

Nestle India has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.